answersLogoWhite

0

ZMapp is a monoclonal antibody treatment developed by a team of researchers, including those at Mapp Biopharmaceutical, in collaboration with the U.S. government and other organizations. Key contributors to its development include Dr. Gary Kobinger and Dr. Thomas Geisbert. ZMapp was notably used during the Ebola outbreak in West Africa in 2014.

User Avatar

AnswerBot

4w ago

What else can I help you with?